These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9143054)
1. Brachytherapy in primary ocular tumors. Freire JE; De Potter P; Brady LW; Longton WA Semin Surg Oncol; 1997; 13(3):167-76. PubMed ID: 9143054 [TBL] [Abstract][Full Text] [Related]
2. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review. Vonk DT; Kim Y; Javid C; Gordon JD; Stea B Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804 [TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22. Collaborative Ocular Melanoma Study Group Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376 [TBL] [Abstract][Full Text] [Related]
4. Ocular complications following I-125 brachytherapy for choroidal melanoma. Wen JC; Oliver SC; McCannel TA Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865 [TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma. Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699 [TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655 [TBL] [Abstract][Full Text] [Related]
7. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224 [TBL] [Abstract][Full Text] [Related]
9. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy. Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215 [TBL] [Abstract][Full Text] [Related]
10. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG; Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159 [TBL] [Abstract][Full Text] [Related]
11. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM; Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893 [TBL] [Abstract][Full Text] [Related]
12. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804 [TBL] [Abstract][Full Text] [Related]
13. Golden Jubilee Lecture. Randomised clinical trials of choroidal melanoma treatment. Straatsma BR Indian J Ophthalmol; 2003 Mar; 51(1):17-23. PubMed ID: 12701858 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188 [TBL] [Abstract][Full Text] [Related]
16. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using Lee YC; Lin SC; Kim Y Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782 [TBL] [Abstract][Full Text] [Related]
18. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related]
19. External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines. Hernandez JC; Brady LW; Shields JA; Shields CL; DePotter P; Karlsson UL; Markoe AM; Amendola BE; Singh A Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):125-32. PubMed ID: 8641908 [TBL] [Abstract][Full Text] [Related]
20. Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: a single surgeon experience. Karlovits B; Trombetta MG; Verstraeten T; Johnson M; Wong M; Karlovits S Brachytherapy; 2011; 10(3):228-31. PubMed ID: 20932809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]